about
Angiogenic, inflammatory and immunologic markers in predicting response to sunitinib in metastatic renal cell carcinoma.Baseline risk stratification or duration of prior therapy predicts prognosis in patients with metastatic renal cell carcinoma treated with axitinib.Impact of baseline visceral fat accumulation on prognosis in patients with metastatic renal cell carcinoma treated with systemic therapy.Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinomaClinical significance of programmed death-1 and programmed death-ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma.
P50
description
researcher
@en
wetenschapper
@nl
name
Ryuichi Mizuno
@en
Ryuichi Mizuno
@nl
type
label
Ryuichi Mizuno
@en
Ryuichi Mizuno
@nl
prefLabel
Ryuichi Mizuno
@en
Ryuichi Mizuno
@nl
P31
P496
0000-0002-1507-1421